BCL2 and neoplasm: The BCL2 gene was found to be aberrantly overexpressed in a wide range of human tumours, including B-cell and T-cell lymphomas, breast, lung, prostate, cervical and colorectal cancers as well as gliomas, melanomas and neuroplastomas (4).